CD151 Gene and Protein Expression Provides Independent Prognostic Information for Patients with Adenocarcinoma of the Esophagus and Gastroesophageal Junction Treated by Esophagectomy-Reference-Cited by-同舟云学术

CD151 Gene and Protein Expression Provides Independent Prognostic Information for Patients with Adenocarcinoma of the Esophagus and Gastroesophageal Junction Treated by Esophagectomy

Published:2016-08-30 Issue:S5 Volume:23 Page:746-754
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Fisher Oliver M.,Levert-Mignon Angelique J.,Lehane Christopher W.,Botelho Natalia K.,Maag Jesper L. V.,Thomas Melissa L.,Edwards Melanie,Lord Sarah J.,Bobryshev Yuri V.,Whiteman David C.,Lord Reginald V.

Funder

National Health and Medical Research Council

Swiss National Science Foundation

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-016-5504-9.pdf

Reference37 articles.

1. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104:510–3.

2. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA. 1993;270:1320.